RecruitingNot ApplicableNCT07065721

Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults

CAPAZ-2D: Continuous Glucose Monitoring to Augment and Personalize Self-Management of Type 2 Diabetes in Hispanic/Latinx Young Adults


Sponsor

San Diego State University

Enrollment

40 participants

Start Date

Oct 2, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Type 2 diabetes in increasing common in young adults. Utilizing a mixed-methods, community-based approach, this study offers continuous glucose monitors (CGMs) to young adults with type 2 diabetes for 30 days, and collects both quantitative and qualitative data to understand barriers and facilitators of CGM use, participants' changes in awareness of glucose patterns while using the CGM, and preferences for a CGM-based self-management intervention.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria5

  • adult 18-45 years of age
  • diagnosis of type 2 diabetes in the last 5 years, as evidenced in the electronic medical record
  • no prior use or experience with wearable CGMs
  • possession of a smart phone that is compatible with Dexcom CGM sensors (nearly all smartphones are compatible) and willing to download and utilize the Dexcom CGM app
  • fluency in English or Spanish

Exclusion Criteria2

  • severe mental illness (e.g., psychosis, suicidal ideation);
  • pregnancy or <6 months postpartum

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEContinuous glucose monitor

Participants will wear a continuous glucose monitoring sensor for 30 days. They will also wear a FitBit wrist watch to be able to track their physical activity and they will complete weekly surveys to report diabetes self-management behaviors. After the 30 days, they will participate in a qualitative interview to respond to questions about their experiences.


Locations(1)

Scripps Health

San Diego, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07065721


Related Trials